Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension

S. Saleemi (Riyadh, Saudi Arabia), A. Aldalaan (Riyadh, Saudi Arabia), I. Weheba (Riyadh, Saudi Arabia)

Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Session: Molecular mechanisms and treatment of pulmonary hypertension
Session type: Oral Presentation
Number: 3279
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Saleemi (Riyadh, Saudi Arabia), A. Aldalaan (Riyadh, Saudi Arabia), I. Weheba (Riyadh, Saudi Arabia). Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension. 3279

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: